3-Min Depression Tx OK'd; Phase II Success for Novel Schizophrenia Drug

A new meta-analysis representing 11 countries found nearly 25% of psychiatric hospital admissions of children and adolescents were involuntary, with Black children seeing a nearly three-times higher odds of involuntary hospitalization than white children. (The Lancet Child and Adolescent Health)

Despite using different PTSD checklist instruments, DSM-4 and DSM-5 criteria were largely agreeable in diagnosing PTSD among a military cohort. (JAMA Network Open)

Exposure to air pollution in childhood, especially to traffic-related air pollutants including nitrogen oxides, was tied to a higher risk of mental illness by early adulthood. (ScienceDaily)

The FDA granted 501(k) clearance to BrainsWay's 3-minute protocol with its Deep Transcranial Magnetic Stimulation system for the treatment of major depressive disorder.

The investigational acute schizophrenia treatment brilaroxazine succeeded in a phase II trial in reducing positive and negative symptoms versus placebo while demonstrating safety without any metabolic or endocrine-related side effects, Reviva Pharmaceuticals announced.

Varenicline (Chantix), bupropion (Wellbutrin) and nicotine patches for smoking cessation did not increase risk for neuropsychiatric adverse events in patients without a history of a psychiatric disorder. (Addiction)

Losing smell or taste due to COVID-19 infection can have a major impact on people's quality of life, with an ongoing study finding 43% of people with these lingering symptoms reported feeling depressed because of it. "It's important for their health care providers to have real discussions with people about what they can or should do to compensate for their loss, whether it's short term or long term," said Evan Reiter, MD, of Virginia Commonwealth University.

Lower heart rate variability was tied to severity of bipolar depression during a depressive episode, according to a new study. (Journal of Psychosomatic Research)